SIC
AKTS

Salem Investment Counselors’s Aktis Oncology AKTS Stock Holding History

Salem Investment Counselors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Hold
1,000
– – ﹤0.01% 697
2026
Q1 		$17.9K Buy
+1,000
New +$19.4K ﹤0.01% 778

Other funds holding AKTS

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Salem Investment Counselors's AKTS Position: Q2 2026 in Review

Salem Investment Counselors held its Aktis Oncology (AKTS) position steady in Q2 2026 at 1,000 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Salem Investment Counselors first reported a position in AKTS in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Salem Investment Counselors held 1,000 shares of Aktis Oncology worth $32.2K as of Q2 2026.
  • Salem Investment Counselors left its Aktis Oncology share count unchanged in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #697 holding.
  • Salem Investment Counselors first reported a position in Aktis Oncology in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.